Usefulness of HeberFERON® in patients with basal cell carcinoma

• Auteurs principaux: Natacha López Pupo (Auteur), Yarien Manganelly Fonseca (Auteur), María Elena Tablada Robinet (Auteur), Ana Lucía Jacas Portuondo (Auteur), Yaimaris Girón Maturell (Auteur)
• Format: Livre
• Publié: Centro Provincial de Información de Ciencias Médicas, 2021-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Introduction: The basal cell carcinoma is the most frequent epithelial neoplasm, because it constitutes 60-80 % of all the cutaneous cancers.  Objective: To determine the answer to HeberFERON® in patients with basal cell carcinoma.  Methods:  An observational, descriptive and longitudinal study of 9...